Photronics Announces Transition of Chief Technology Officer, Dr. Christopher Progler

Photronics Announces Transition of Chief Technology Officer, Dr. Christopher Progler GlobeNewswire January 02, 2026 BROOKFIELD, Conn., Jan. 02, 2026 (GLOBE NEWSWIRE) — Photronics, Inc. (Nasdaq: PLAB), a worldwide leader in photomask technologies and solutions, today announced that Dr. Christopher Progler, Executive Vice President and Chief Technology Officer, will be stepping away from his current role […]

XAI Madison Equity Premium Income Fund Declares its Monthly Distribution of $0.060 per Share

XAI Madison Equity Premium Income Fund Declares its Monthly Distribution of $0.060 per Share GlobeNewswire January 02, 2026 CHICAGO, Jan. 02, 2026 (GLOBE NEWSWIRE) — XAI Madison Equity Premium Income Fund (the “Fund”) has declared its regular monthly distribution of $0.060 per share on the Fund's common shares (NYSE: MCN), payable on January 30, 2026,

Special Opportunities Fund Declares Distributions For First Quarter of 2026

(NYSE:SPE), NEW YORK, Jan. 02, 2026 (GLOBE NEWSWIRE) — Special Opportunities Fund, Inc. (NYSE: SPE) (the “Fund”) today announced that the Fund's Board of Directors (the “Board”) has declared the next three monthly distributions under the Fund's managed distribution plan. Under the Fund's managed distribution plan, the Fund intends to make monthly distributions to common

Special Opportunities Fund Declares Distributions For First Quarter of 2026

Special Opportunities Fund Declares Distributions For First Quarter of 2026 GlobeNewswire January 02, 2026 NEW YORK, Jan. 02, 2026 (GLOBE NEWSWIRE) — Special Opportunities Fund, Inc. (NYSE: SPE) (the “Fund”) today announced that the Fund's Board of Directors (the “Board”) has declared the next three monthly distributions under the Fund's managed distribution plan. Under the

NCL Founder and CEO Lin Li Provides Letter to Stockholders, Highlighting North American Retail

(NYSE MKT:NCL), Fort Lawn, SC, Jan. 02, 2026 (GLOBE NEWSWIRE) — Northann Corp. (NYSE American: NCL) (the “Company”), an innovator in integrated interior surface solutions, today announced that its founder and CEO, Lin Li, has provided a letter to the Company's stockholders. The letter outlines the Company's strategic roadmap for 2026, including its expansion into

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

(NASDAQ:TERN), FOSTER CITY, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced that it has granted as of January 1, 2026 equity inducement awards to two new employees under the terms of the 2022 Employment Inducement Award Plan, as amended. The equity

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

(NasdaqGM:RXST), ALISO VIEJO, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) — RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference. RxSight's management is scheduled to present on Tuesday, January 13, 2026, at 3:45 p.m. Pacific

Horizon Bancorp, Inc. Announces Conference Call to Review Fourth Quarter Results on January 22

(NASDAQ:HBNC), MICHIGAN CITY, Ind., Jan. 02, 2026 (GLOBE NEWSWIRE) — Horizon Bancorp, Inc. (“Horizon” or the “Company”) will host a conference call at 7:30 a.m. CT on Thursday, January 22, 2026, to review its fourth quarter 2025 financial results. The Company's fourth quarter 2025 news release will be published after markets close on Wednesday, January

Safe Bulkers, Inc. Declares Quarterly Dividend on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares; 8.00% Series D Cumulative Redeemable Perpetual Preferred Shares

(NYSE:SB),(NYSE:SB-PC),(NYSE:SB-PD), MONACO, Jan. 02, 2026 (GLOBE NEWSWIRE) — Safe Bulkers, Inc. (the “Company”) (NYSE: SB), an international provider of marine drybulk transportation services, announced today that the Company's Board of Directors has declared: a cash dividend of $0.50 per share on its 8.00% Series C Cumulative Redeemable Perpetual Preferred Shares (the “Series C Preferred Shares”)

Regeneron to Report Fourth Quarter and Full Year 2025 Financial and Operating Results and Host Conference Call and Webcast on January 30, 2026

(NASDAQ:REGN), TARRYTOWN, N.Y., Jan. 02, 2026 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its fourth quarter and full year 2025 financial and operating results on Friday, January 30, 2026, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM

Scroll to Top